Quarterly Result23 Jul 2026, 12:41 pm
Cipla Q1FY27 Revenue ₹7,119 Cr, PAT ₹789 Cr
AI Summary
Cipla Limited announced its unaudited consolidated financial results for the quarter ended June 30th, 2026 (Q1FY27). The company reported global revenues of INR 7,119 Cr, with a Profit After Tax (PAT) of INR 789 Cr. The One-India business showed strong performance with 12% YoY growth, driven by improved chronic mix to 60.4%. North America contributed $162 Mn in revenue, with new product launches including gVentolin, Nintedanib, and Dapagliflozin. The Emerging Markets and Europe segment grew 5% YoY in USD terms. R&D investments stood at INR 486 Cr, representing 6.8% of sales. The company maintained a strong net cash position of INR 9,494 Cr.
Key Highlights
- Global revenues reached INR 7,119 Cr in Q1FY27.
- One-India business grew 12% YoY, with chronic mix at 60.4%.
- North America revenue was $162 Mn, with new product launches.
- R&D investments increased 12.3% YoY to INR 486 Cr.
- Net cash position remains strong at INR 9,494 Cr.
Price Impact
More from CIPLA